| Drug Name | (Plavix ( Clopidogrel |
|---|---|
| Drug Class |
Anticoagulant
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
Safety communication
|
| Specialty (Theraputic area) |
Hematology
|
| Risk |
Enhanced Hypoglycemic Effect of Repaglinide Due to Drug-Drug Interaction with Clopidogrel. Regarding Bleeding Risk with Plavix in Atrial Fibrillation Patients |
| safety communication |
|
| Dear Healthcare provider letter DHPC |
|